Top compounds associated with response to ZNF883


Feature Type Standardized
Nominal ANOVA
mRNA Axitinib CTRPv2 pan-cancer AAC 0.024 0.5
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.023 0.5
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.025 0.5
mRNA PLX4720 CTRPv2 pan-cancer AAC 0.024 0.5
mRNA triptolide CTRPv2 pan-cancer AAC 0.024 0.5
mRNA MGCD-265 CTRPv2 pan-cancer AAC 0.024 0.5
mRNA Crizotinib CCLE pan-cancer AAC -0.033 0.5
mRNA MI-2 CTRPv2 pan-cancer AAC 0.038 0.5
mRNA nintedanib CTRPv2 pan-cancer AAC -0.026 0.5
mRNA lapatinib GDSC1000 pan-cancer AAC 0.035 0.5
Download CSV